Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ Management Team

Mr. Constantine Chinoporos

Chief Operating Officer and Chief Business Officer

Age 58

Compensation -

Sex Male

Mr. John Johnson

Executive Chairman of the Board

Age 67

Compensation $2.842M USD

Sex Male

Mr. Leslie Funtleyder

Interim Chief Executive Officer

Chief Financial Officer

Age 55

Compensation $1.054M USD

Sex Male

Ms. Catherine Thorpe

Interim Chief Accounting Officer

Age 62

Compensation -

Sex Female

Mr. Dale Hooks

Chief Commercial Officer

Age 58

Compensation $2.060M USD

Sex Male

Dr. Evan Bailey

Chief Medical Officer

Age 44

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Constantine Chinoporos Chief Operating Officer and Chief Business Officer	58	-	Male
Mr. John Johnson Executive Chairman of the Board	67	$2.842M USD	Male
Mr. Leslie Funtleyder Interim Chief Executive Officer Chief Financial Officer	55	$1.054M USD	Male
Ms. Catherine Thorpe Interim Chief Accounting Officer	62	-	Female
Mr. Dale Hooks Chief Commercial Officer	58	$2.060M USD	Male
Dr. Evan Bailey Chief Medical Officer	44	-	Male

Board of Directors

From the proxy statement filed Apr 28, 2025

Directors

serving now

Independent

3 of 5

stated in the proxy

Average tenure

7.2 years

from year joined

CEO also chairs the board

John H. Johnson

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Teena Lerner Lead independent director	67	2017 8 years	Independent	Audit Committee	None stated	Not stated
Les Funtleyder CEO, Executive officer	55	2016 9 years	Not independent	None stated	Reviva Pharmaceuticals Holdings, Inc.	Paid as CEO
Stacy J. Kanter	66	2019 6 years	Independent	Audit Committee · Chair	Oppenheimer Holdings Inc.	$267,500
Jay S. Skyler	78	2019 6 years	Independent	Compensation Committee · Chair	SAB Biotherapeutics, Inc.	$267,500
John H. Johnson Board chair	67	Not stated	Not independent	None stated	Verastem, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ Management Team

Mr. Constantine Chinoporos

Mr. John Johnson

Mr. Leslie Funtleyder

Ms. Catherine Thorpe

Mr. Dale Hooks

Dr. Evan Bailey

Board of Directors

Related-party transactions

No related-party transactions disclosed